Saera Khan

Leslie Nelson supports the Defense Health Agency’s mission to ensure operational readiness through strategic procurement of advanced medical research, diagnostic technologies, and life sciences solutions. While her official title is not publicly listed, her procurement activities center on high-priority R&D contracts that enhance clinical capabilities across the global DoD healthcare network. She routinely manages acquisitions in biotechnology, medical device support, and life sciences innovation, aligning with DHA’s focus on modernizing clinical workflows and securing next-generation pharmaceutical and diagnostic infrastructure. Her work directly enables the agency’s commitment to maintaining cutting-edge medical readiness for service members, retirees, and their families. Nelson maintains consistent contracting relationships with specialized firms including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These partnerships reflect a preference for niche vendors delivering tailored solutions in biomedical research, medical equipment maintenance, data security, and clinical support services. Her contracting patterns suggest a focus on agile, technically proficient contractors capable of meeting stringent DoD compliance and operational requirements, often engaging firms with proven expertise in regulated healthcare environments. Her procurement portfolio shows a strong inclination toward open competition, with 87.5% of awards issued without set-aside designations, indicating a priority on technical merit and capability over socioeconomic preferences. However, she consistently allocates 12.5% of awards to Women-Owned Small Businesses, demonstrating a measured but intentional commitment to expanding opportunities for underrepresented entrepreneurs in high-tech medical contracting. Nelson’s primary NAICS focus lies in biotechnology research (541714) and physical/engineering life sciences R&D (541715), underscoring her specialization in procuring innovative medical technologies, diagnostic platforms, and clinical research support services. She frequently sources advanced laboratory equipment, biosafety systems, and data-driven health analytics tools, reflecting deep expertise in the intersection of defense medicine and scientific innovation. Her work ensures DHA remains at the forefront of military healthcare advancement through evidence-based, technology-enabled procurement.